list of publications
Heterologous Prime-Boost Immunizations with a Virosomal and an Alphavirus Replicon Vaccine.
Walczak M, de Mare A, Riezebos-Brilman A, Regts J, Hoogeboom BN, Visser JT, Fiedler M, Jansen-Dürr P, van der Zee AG, Nijman HW, Wilschut J, Daemen T.
Mol Pharm. 7 Feb 2011; 8(1)65-77.
Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell, D., Rostek, U., Bouvard, V., Campo-Fernández, B., Fiedler, M. Jansen-Dürr, P., and W. Zwerschke.
Virology 15 Sep 2008; 379(1)20-9.
Premature senescence of human endothelial cells induced by inhibition of glutaminase.
Unterluggauer H, Mazurek S, Lener B, Hütter E, Eigenbrodt E, Zwerschke W, Jansen-Dürr P.
Biogerontology 1 Aug 2008; 9(4)247-59. Epub 2008 Mar 4
Insulin-like growth factor-induced signals activate mitochondrial respiration.
Unterluggauer H, Hütter E, Viertler HP, Jansen-Dürr P.
Biotechnol J 1 Jun 2008; 3(6)813-6. Journal not listed
Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation.
Spoden GA, Mazurek S, Morandell D, Bacher N, Ausserlechner MJ, Jansen-Dürr P, Eigenbrodt E, Zwerschke W.
Int J Cancer 18 Apr 2008; 123(2)312-321. [Epub ahead of print]
Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradation.
Santer FR, Moser B, Spoden GA, Jansen-Dürr P, Zwerschke W.
Carcinogenesis 1 Dec 2007; 28()2511-20.
High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S, Scheiden R, Dreier K, Laich A, Müller-Holzner E, Pircher H, Morandell D, Stein I, Viertler HP, Santer FR, Widschwendter A, Even J, Jansen-Dürr P, Capesius C, Zwerschke W.
Clin Cancer Res 1 Dec 2007; 13()7067-72.
High-risk HPV E7 oncoprotein expression in cervical squamous cell carcinoma.
Ressler, S., Scheiden, R., Dreier, K., Laich, A., Müller-Holzner, E., Pircher, H., Morandell, D., Stein, I., Viertler, H.P., Santer, F.R., Widschwendter, A., Even, J., Jansen-Dürr, P., Capesius, C. and W. Zwerschke
Clin Can Res. 1 Jan 2007; (13)7067-7072.
The human papillomavirus type 16 E7 oncoprotein inhibits
apoptosis induced by nuclear insulin-like growth factor binding
protein-3 by inducing its ubiquitin/proteasome-dependent degradation.
Santer, F., Moser, B., Spoden, G.A., Jansen-Dürr, P., and W. Zwerschke.
Carcinogenesis 1 Jan 2007; 28()2511-2520.
Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16.
Campo-Fernandez B, Morandell D, Santer FR, Zwerschke W, Jansen-Durr P.
J Virol. 1 Jan 2007; 81(2)1027-32. Epub 2006 Nov 8.
Peptide aptamers as isotype-specific inhibitors of the metabolic keyregulator pyruvate kinase subtype M2.
Spoden, G. A., Mazurek, S., Morandell, D., Bacher, N., Ausserlechner, M., Jansen-Dürr, P., Eigenbrodt E., and W. Zwerschke.
Int J Cancer. In press. ; ().